| Nome |
# |
|
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair, file 12e43767-a2b5-447e-892d-246153f464b1
|
1.006
|
|
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score, file dfe4d22b-cd61-bb0a-e053-d805fe0a78d9
|
809
|
|
Sviluppo tecnologico ed implementazione clinica degli scaffold coronarici bio-riassorbibili., file d9673f0a-0fcd-410b-8071-c0ef5f831c65
|
211
|
|
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture, file dfe4d22a-6ff4-bb0a-e053-d805fe0a78d9
|
176
|
|
Terapia antitrombotica nei pazienti sottoposti a impianto transcatetere di valvola aortica: Alla ricerca del Santo Graal [Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: The quest for the Holy Grail], file dfe4d22b-5608-bb0a-e053-d805fe0a78d9
|
80
|
|
Procedural management of patients with advanced heart failure undergoing MitraClip implantation (from the GRASP registry), file dfe4d22b-7e5f-bb0a-e053-d805fe0a78d9
|
51
|
|
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the
GHOST-EU and XIENCE V USA Registries, file dfe4d22b-dd29-bb0a-e053-d805fe0a78d9
|
44
|
|
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients., file dfe4d22a-ef5d-bb0a-e053-d805fe0a78d9
|
43
|
|
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry., file dfe4d22b-daa7-bb0a-e053-d805fe0a78d9
|
42
|
|
MitraClip Implantation for the Treatment of New-Onset Systolic Anterior Motion of the Mitral Valve After Transcatheter Aortic Valve Replacement, file dfe4d22b-7e6e-bb0a-e053-d805fe0a78d9
|
41
|
|
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients, file dfe4d22b-e534-bb0a-e053-d805fe0a78d9
|
31
|
|
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry, file dfe4d22b-c3db-bb0a-e053-d805fe0a78d9
|
29
|
|
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey, file dfe4d22e-1d2c-bb0a-e053-d805fe0a78d9
|
23
|
|
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement, file dfe4d22e-8c1a-bb0a-e053-d805fe0a78d9
|
21
|
|
Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry, file dfe4d22b-c3dd-bb0a-e053-d805fe0a78d9
|
19
|
|
Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry, file dfe4d22b-7e5e-bb0a-e053-d805fe0a78d9
|
18
|
|
Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry, file dfe4d22b-a5e2-bb0a-e053-d805fe0a78d9
|
18
|
|
Transcatheter Aortic-Valve Replacement, file dfe4d22b-8025-bb0a-e053-d805fe0a78d9
|
16
|
|
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation), file dfe4d22b-7e5d-bb0a-e053-d805fe0a78d9
|
14
|
|
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients., file dfe4d229-40c3-bb0a-e053-d805fe0a78d9
|
13
|
|
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry, file dfe4d22b-612a-bb0a-e053-d805fe0a78d9
|
12
|
|
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial, file dfe4d22b-d0b1-bb0a-e053-d805fe0a78d9
|
12
|
|
European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection, file dfe4d22d-28a1-bb0a-e053-d805fe0a78d9
|
12
|
|
Embolization of fractured bioresorbable scaffold struts: insights from 2- and 3-dimensional optical coherence tomography, file dfe4d22a-7594-bb0a-e053-d805fe0a78d9
|
11
|
|
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality?, file dfe4d22b-18e0-bb0a-e053-d805fe0a78d9
|
11
|
|
Tailoring P2Y12 Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention, file dfe4d22b-4b76-bb0a-e053-d805fe0a78d9
|
11
|
|
Bioresorbable vascular scaffolds in left main coronary artery disease, file dfe4d22a-f660-bb0a-e053-d805fe0a78d9
|
10
|
|
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement, file dfe4d22b-911f-bb0a-e053-d805fe0a78d9
|
10
|
|
Update on clinical evidence (Part II): a summary of the main post market studies, file dfe4d22b-e099-bb0a-e053-d805fe0a78d9
|
10
|
|
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery, file dfe4d22a-f65d-bb0a-e053-d805fe0a78d9
|
9
|
|
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography, file dfe4d22b-13b9-bb0a-e053-d805fe0a78d9
|
9
|
|
Timing of cardioversion in atrial fibrillation: The sooner the better?, file dfe4d22e-a306-bb0a-e053-d805fe0a78d9
|
9
|
|
Longitudinal elongation, axial compression, and effects on strut geometry of bioresorbable vascular scaffolds: insights from 2- and 3-dimensional optical coherence tomography imaging, file dfe4d22a-e183-bb0a-e053-d805fe0a78d9
|
8
|
|
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations, file dfe4d22b-a891-bb0a-e053-d805fe0a78d9
|
8
|
|
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI, file dfe4d22d-289f-bb0a-e053-d805fe0a78d9
|
8
|
|
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR, file 2c3cccb1-7460-4ded-ac48-f0e4c73a55be
|
6
|
|
Tug of War Between Dual and Triple Antithrombotic Therapy in Atrial Fibrillation/PCI Patients With CKD, file dfe4d22b-4b78-bb0a-e053-d805fe0a78d9
|
6
|
|
The sunset of triple antithrombotic therapy for atrial fibrillation patients, file dfe4d22b-4b7c-bb0a-e053-d805fe0a78d9
|
6
|
|
Motivations for and barriers to choosing an interventional cardiology career path: Results from the EAPCI Women Committee worldwide survey, file dfe4d22e-1d2a-bb0a-e053-d805fe0a78d9
|
6
|
|
Early and Midterm Outcomes of Bioresorbable Scaffolds for Ostial Coronary Lesions: Insights from the GHOST-EU Registry, file dfe4d22b-8c39-bb0a-e053-d805fe0a78d9
|
5
|
|
Evidence and Recommendations for Uninterrupted Versus Interrupted Oral Anticoagulation in Patients Undergoing Percutaneous Coronary Intervention, file 5332a340-203b-469f-83e4-ad0b452787f9
|
4
|
|
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions, file dfe4d22e-3616-bb0a-e053-d805fe0a78d9
|
4
|
|
Antithrombotic Management of Elderly Patients With Coronary Artery Disease, file f3ef58b6-f191-4d75-94ce-c9157df23598
|
4
|
|
Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study, file 0902c6fc-74e6-43c3-a6a2-84ddc4f8ca44
|
3
|
|
Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN-TAVI registry, file 15689f10-2375-4f7d-8453-a3a5ff5c794f
|
3
|
|
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries, file 76037c35-5bff-46ee-9741-3fbacb04dbdd
|
3
|
|
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment, file dfe4d22b-8414-bb0a-e053-d805fe0a78d9
|
3
|
|
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry., file dfe4d22b-89f3-bb0a-e053-d805fe0a78d9
|
3
|
|
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective., file dfe4d22b-8a9c-bb0a-e053-d805fe0a78d9
|
3
|
|
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry, file fa6d27ce-f3b9-4c02-8851-edc579cd35a1
|
3
|
|
The stent in the high-bleeding risk patient: antiplatelet monotherapy?, file 6c68c3b9-575c-4a16-ad2e-18acc100771e
|
2
|
|
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity., file dfe4d227-1fe1-bb0a-e053-d805fe0a78d9
|
2
|
|
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease, file dfe4d227-93e3-bb0a-e053-d805fe0a78d9
|
2
|
|
Early cardiovascular remodelling in Fabry disease, file dfe4d229-87f8-bb0a-e053-d805fe0a78d9
|
2
|
|
Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug eluting stents for percutaneous treatment of chronic total coronary occlusions: technical and procedural outcomes from the GHOST-CTO registry, file dfe4d22b-13b8-bb0a-e053-d805fe0a78d9
|
2
|
|
Balancing the expansion of transcatheter interventions for heart valve disease, file dfe4d22b-1e54-bb0a-e053-d805fe0a78d9
|
2
|
|
Impact of Chronic Kidney Disease on Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Insights From the GRASP Registry, file dfe4d22b-8796-bb0a-e053-d805fe0a78d9
|
2
|
|
New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: a causal or spurious association?, file dfe4d22b-a2d9-bb0a-e053-d805fe0a78d9
|
2
|
|
Basics of Antiplatelet and Anticoagulant Therapy for Cardiovascular Disease, file dfe4d22d-ef2c-bb0a-e053-d805fe0a78d9
|
2
|
|
Tecnica di impianto dello scaffold coronarico riassorbibile AbsorbTM nel registro IT-DISAPPEARS [Technical features of Absorb(TM) BVS implantation in the IT-DISAPPEARS registry], file c2d7b12d-af6a-4c0c-98b5-335517ad6ba9
|
1
|
|
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study, file cf41e297-3ac5-433c-86ff-f3a820d47b65
|
1
|
|
Impact of direct oral anticoagulants on evolution of post-thrombotic syndrome, file d9fad56f-aa5f-4bee-a295-dfe0a553ebca
|
1
|
|
Treatment of multilesion coronary artery disease with simultaneous Drug eluting and bare metal stent implantation: Clinical and angiographic mid-term results, file dfe4d227-15f1-bb0a-e053-d805fe0a78d9
|
1
|
|
Increasing CHADS2 scores may attenuate the benefit of novel oral anticoagulants
versus warfarin in reducing intracranial bleeding, file dfe4d227-204b-bb0a-e053-d805fe0a78d9
|
1
|
|
La trombosi dello stent medicato prima e dopo sospensione delle tienopiridine, tra enfasi e realtà: la dimensione del problema, file dfe4d227-2ea7-bb0a-e053-d805fe0a78d9
|
1
|
|
Real world safety and efficacy of the janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting Stent (TEST) registry, file dfe4d227-8253-bb0a-e053-d805fe0a78d9
|
1
|
|
Long-term outcomes comparison of different types of DES in elderly patients from a real world experience, file dfe4d227-a65b-bb0a-e053-d805fe0a78d9
|
1
|
|
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score, file dfe4d227-b68d-bb0a-e053-d805fe0a78d9
|
1
|
|
Impact of moderate preoperative chronic kidney disease on mortality after transcatheter aortic valve implantation, file dfe4d22a-9914-bb0a-e053-d805fe0a78d9
|
1
|
|
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike?, file dfe4d22a-c5df-bb0a-e053-d805fe0a78d9
|
1
|
|
Retrograde Approach for Chronic Total Occlusion Percutaneous Coronary Intervention: The Paradox of Choice, file dfe4d22a-e03d-bb0a-e053-d805fe0a78d9
|
1
|
|
Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial, file dfe4d22a-f4bb-bb0a-e053-d805fe0a78d9
|
1
|
|
De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus, file dfe4d22b-45ac-bb0a-e053-d805fe0a78d9
|
1
|
|
Pharmacodynamics During Transition Between Platelet P2Y12 Inhibiting Therapies, file dfe4d22b-4865-bb0a-e053-d805fe0a78d9
|
1
|
|
One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy?, file dfe4d22b-6e62-bb0a-e053-d805fe0a78d9
|
1
|
|
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: insights from the European multicenter GHOST-EU registry, file dfe4d22b-911d-bb0a-e053-d805fe0a78d9
|
1
|
|
Bioresorbable vascular scaffold in patients with complex coronary artery disease., file dfe4d22b-b889-bb0a-e053-d805fe0a78d9
|
1
|
|
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry, file dfe4d22b-e09f-bb0a-e053-d805fe0a78d9
|
1
|
|
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry, file dfe4d22b-e1d2-bb0a-e053-d805fe0a78d9
|
1
|
|
Percutaneous Coronary Intervention With Everolimus-Eluting Bioresorbable Vascular Scaffolds In Routine Clinical Practice: Early and Mid-Term Outcomes From The European Multicenter GHOST-EU Registry, file dfe4d22b-e236-bb0a-e053-d805fe0a78d9
|
1
|
|
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy, file dfe4d22c-0884-bb0a-e053-d805fe0a78d9
|
1
|
|
Early Results of MitraClip System Implantation by Real-Time Three-Dimensional Speckle-Tracking Left Ventricle Analaysis, file dfe4d22c-0a43-bb0a-e053-d805fe0a78d9
|
1
|
|
Appraisal of key trials in aortic and mitral fields, file dfe4d22c-1641-bb0a-e053-d805fe0a78d9
|
1
|
|
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair, file dfe4d22c-f9b7-bb0a-e053-d805fe0a78d9
|
1
|
| Totale |
2.960 |